113 related articles for article (PubMed ID: 19228737)
1. A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples.
Sánchez-Espiridión B; Sánchez-Aguilera A; Montalbán C; Martin C; Martinez R; González-Carrero J; Poderos C; Bellas C; Fresno MF; Morante C; Mestre MJ; Mendez M; Mazorra F; Conde E; Castaño A; Sánchez-Godoy P; Tomas JF; Morente MM; Piris MA; García JF;
Clin Cancer Res; 2009 Feb; 15(4):1367-75. PubMed ID: 19228737
[TBL] [Abstract][Full Text] [Related]
2. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
[TBL] [Abstract][Full Text] [Related]
3. Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue.
Hartmann E; Fernàndez V; Moreno V; Valls J; Hernández L; Bosch F; Abrisqueta P; Klapper W; Dreyling M; Hoster E; Müller-Hermelink HK; Ott G; Rosenwald A; Campo E
J Clin Oncol; 2008 Oct; 26(30):4966-72. PubMed ID: 18606985
[TBL] [Abstract][Full Text] [Related]
4. Detection of immunoglobulin heavy chain gene rearrangements in classic hodgkin lymphoma using commercially available BIOMED-2 primers.
Chute DJ; Cousar JB; Mahadevan MS; Siegrist KA; Silverman LM; Stoler MH
Diagn Mol Pathol; 2008 Jun; 17(2):65-72. PubMed ID: 18382369
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
6. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.
Alvaro T; Lejeune M; Salvadó MT; Bosch R; García JF; Jaén J; Banham AH; Roncador G; Montalbán C; Piris MA
Clin Cancer Res; 2005 Feb; 11(4):1467-73. PubMed ID: 15746048
[TBL] [Abstract][Full Text] [Related]
7. Optimization of RNA extraction from formalin-fixed, paraffin-embedded lymphoid tissues.
Chen J; Byrne GE; Lossos IS
Diagn Mol Pathol; 2007 Jun; 16(2):61-72. PubMed ID: 17525674
[TBL] [Abstract][Full Text] [Related]
8. Reliability and reproducibility of a RNA preamplification method for low-density array analysis from formalin-fixed paraffin-embedded breast cancer samples.
Ciotti P; Garuti A; Ballestrero A; Cirmena G; Chiaramondia M; Baccini P; Bellone E; Mandich P
Diagn Mol Pathol; 2009 Jun; 18(2):112-8. PubMed ID: 19430292
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group.
Nogová L; Reineke T; Brillant C; Sieniawski M; Rüdiger T; Josting A; Bredenfeld H; Skripnitchenko R; Müller RP; Müller-Hermelink HK; Diehl V; Engert A;
J Clin Oncol; 2008 Jan; 26(3):434-9. PubMed ID: 18086799
[TBL] [Abstract][Full Text] [Related]
10. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
[TBL] [Abstract][Full Text] [Related]
11. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs.
Staege MS; Banning-Eichenseer U; Weissflog G; Volkmer I; Burdach S; Richter G; Mauz-Körholz C; Föll J; Körholz D
Exp Hematol; 2008 Jul; 36(7):886-96. PubMed ID: 18400362
[TBL] [Abstract][Full Text] [Related]
13. Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines.
Hartlapp I; Pallasch C; Weibert G; Kemkers A; Hummel M; Re D
Leuk Res; 2009 Jul; 33(7):929-36. PubMed ID: 19233470
[TBL] [Abstract][Full Text] [Related]
14. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging.
Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C
Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517
[TBL] [Abstract][Full Text] [Related]
15. A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma.
Sánchez-Espiridión B; Montalbán C; López A; Menárguez J; Sabín P; Ruiz-Marcellán C; Lopez A; Ramos R; Rodríguez J; Cánovas A; Camarero C; Canales M; Alves J; Arranz R; Acevedo A; Salar A; Serrano S; Bas A; Moraleda JM; Sánchez-Godoy P; Burgos F; Rayón C; Fresno MF; Laraña JG; García-Cosío M; Santonja C; López JL; Llanos M; Mollejo M; González-Carrero J; Marín A; Forteza J; García-Sanz R; Tomás JF; Morente MM; Piris MA; García JF;
Blood; 2010 Aug; 116(8):e12-7. PubMed ID: 20479282
[TBL] [Abstract][Full Text] [Related]
16. Classical Hodgkin's lymphoma arising in different host's conditions: pathobiology parameters, therapeutic options, and outcome.
Carbone A; Spina M; Gloghini A; Tirelli U
Am J Hematol; 2011 Feb; 86(2):170-9. PubMed ID: 21264899
[TBL] [Abstract][Full Text] [Related]
17. Real-time quantitative reverse transcriptase-polymerase chain reaction analysis of melanoma progression-associated genes.
Rafferty M; Faller WJ; Moss C; McCormack J; Mãlandsmo GM; Easty DJ; Gallagher WM
Anticancer Res; 2007; 27(3A):1301-7. PubMed ID: 17593623
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma.
Martini M; Hohaus S; Petrucci G; Cenci T; Pierconti F; Massini G; Teofili L; Leone G; Larocca LM
Am J Clin Pathol; 2008 Mar; 129(3):472-7. PubMed ID: 18285272
[TBL] [Abstract][Full Text] [Related]
19. Characterization and expression of CT45 in Hodgkin's lymphoma.
Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells.
Alvaro T; Lejeune M; García JF; Salvadó MT; López C; Bosch R; Jaén J; Escrivá P; Pons LE
Clin Cancer Res; 2008 Feb; 14(3):685-91. PubMed ID: 18245527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
